Sterghios A. Moschos
@docmoschos.bsky.social
Founder and CEO of PulmoBioMed Ltd. Visiting Professor in Biosciences, Northumbria University. All things respiratory science and RNA biology.
At the #ATS2025 #RIS innovation in Respiratory Medicine is truly reaching new heights, poised to transform patient quality of life.
From repurposing statins for asthma to surfactant peptidomimetics and targeted degradation of kinases, the field is ripe and ready to resolve unmet need.
1/n
From repurposing statins for asthma to surfactant peptidomimetics and targeted degradation of kinases, the field is ripe and ready to resolve unmet need.
1/n
May 17, 2025 at 11:20 PM